EP2308428A1 — Device and method for reversible office sterilization
Assigned to Bio Material Systems · Expires 2011-04-13 · 15y expired
What this patent protects
The invention relates in the first place to a copper- releasing device (UTD) of extremely reduced dimensions and surface area to minimize the impact on menstrual blood loss. The device, consisting of hollow elements is constructed in a specific way to increase the lifespan of the…
USPTO Abstract
The invention relates in the first place to a copper- releasing device (UTD) of extremely reduced dimensions and surface area to minimize the impact on menstrual blood loss. The device, consisting of hollow elements is constructed in a specific way to increase the lifespan of the UTD without reducing the exchange between the active substance of the device and the utero-tubal environment in order not to jeopardize the effectiveness of the contraceptive device. Secondly, the invention relates also to a frameless utero-tubal hormone-releasing system (UTS), for contraception and treatment purposes, of reduced dimensions consisting of a coaxial, flexible rod, or multiple fibers, constructed in a specific way to increase the lifespan of the UTS.
Drugs covered by this patent
- Arnicare Leg Cramps (COPPER) · Sebela Womens Hlth
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.